MedTrace Logo

Patient-led Surveillance Compared to Clinician-led Surveillance in People Treated for Localised Melanoma.

NCT03581188 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2023-08-01

Study results available
· View outcomes & findings →

Summary

The purpose of this pilot study is to evaluate digitally supported skin self-examination compared to usual care in people treated for localised melanoma.

Conditions

  • Melanoma (Skin)

Interventions

DEVICE

Patient-led surveillance

Usual care plus reminders, ASICA instructional videos, a mobile dermatoscope, an app that facilitates store-and-forward teledermatology, and fast-tracked unscheduled clinic visits.

BEHAVIORAL

Clinician-led surveillance

Usual care (scheduled clinician visits)

Sponsors & Collaborators

  • Melanoma and Skin Cancer Trials Limited

    collaborator OTHER

  • University of Sydney

    lead OTHER

Principal Investigators

  • Katy Bell, A/Prof · University of Sydney

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-01
Primary Completion
2020-02-17
Completion
2020-02-17

Countries

  • Australia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03581188 on ClinicalTrials.gov